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http://www.biomedcentral.com/1472-6882/14/428RESEARCH ARTICLE Open AccessDendropanax morbifera Léveille extract facilitates
cadmium excretion and prevents oxidative
damage in the hippocampus by increasing
antioxidant levels in cadmium-exposed rats
Woosuk Kim1, Dae Won Kim2, Dae Young Yoo1, Hyo Young Jung1, Sung Min Nam1, Jong Whi Kim1,
Soon-Min Hong3, Dong-Woo Kim3, Jung Hoon Choi4, Seung Myung Moon5, Yeo Sung Yoon1 and In Koo Hwang1*Abstract
Background: Dendropanax morbifera Léveille is used in herbal medicine as a cancer treatment. In this study, we
investigated the effects of Dendropanax morbifera stem extract (DMS) on cadmium (Cd) excretion from the blood
and kidney and brain tissues of rats exposed to cadmium, as well as the effects of DMS on oxidative stress and
antioxidant levels in the hippocampus after Cd exposure.
Methods: Seven-week-old Sprague-Dawley rats were exposed to 2 mg/kg of cadmium by intragastric gavage and
were orally administered 100 mg/kg of DMS for 4 weeks. Animals were sacrificed and Cd determination was performed
using inductively coupled plasma mass spectrometry. In addition, the effects of Cd and/or DMS on oxidative stress were
assayed by measuring reactive oxygen species production, protein carbonyl modification, lipid peroxidation levels, and
antioxidant levels in hippocampal homogenates.
Results: Exposure to Cd significantly increased Cd content in the blood, kidneys, and hippocampi. DMS treatment
significantly reduced Cd content in the blood and kidneys, but not in the hippocampi. Exposure to Cd significantly
increased reactive oxygen species production, protein carbonyl modification, lipid peroxidation, total sulfhydryl content,
reduced glutathione content, and glutathione reductase activity. In contrast, Cu, Zn-superoxide dismutase (SOD1),
catalase (CAT), glutathione peroxidase (GPx), and glutathione-S-transferase (GST) activity in the hippocampus were
significantly decreased after exposure to Cd, and administration of DMS significantly inhibited these Cd-induced
changes.
Conclusion: These results indicate that DMS facilitates cadmium excretion from the kidneys, reduces cadmium-induced
oxidative stress in the hippocampus, and modulates SOD1, CAT, GPx, and glutathione-S-transferase activities.
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Dendropanax morbifera Léveille is mainly distributed in
southwestern Korea. This tree was initially used for the
production of golden varnish [1], but the leaves, stems,
roots, and seeds contain compounds that are used in
traditional medicine for the treatment of skin and* Correspondence: vetmed2@snu.ac.kr
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unless otherwise stated.infectious diseases, headaches, and other maladies [2].
The polyacetylene compounds in Dendropanax morbi-
fera leaves have anti-complement, anti-diabetic, and
anti-atherogenic activities [1,3-5].
Cadmium (Cd) is one of the most harmful heavy
metals in nature and it is released into the environment
through mining and smelting. The main sources of Cd
exposure include production of certain types of batteries,
intake of contaminated food and water, and inhalation of
tobacco smoke or polluted air [6,7]. Cd exposure generates
free radicals such as superoxide radicals, hydroxyl radicals,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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is harmful to tissue types in many organs, including the
brain and spinal cord. The nervous system is highly sus-
ceptible to damage induced by free radicals because ner-
vous tissue contains high levels of unsaturated fatty acids
and iron [9]. Cd exposure induces oxidative DNA damage
due to excess oxygen-derived free radicals [10,11] and de-
pletes antioxidant levels, resulting in a state of oxidant/
antioxidant imbalance. Therefore, modulation of antioxi-
dant levels in the brain may be an effective strategy with
which to reduce Cd-induced neurotoxicity.
Several approaches have been used to promote or
facilitate the excretion of Cd from the body because it
has a long biological half-life (approximately 30 years
in humans) and readily accumulates in tissues [12].
Debarked Dendropanax morbifera stem extract (DMS)
decreases 2,2-diphenyl-1-picrylhydrazyl radical levels,
and its antioxidant capacity is greater than that of other
organ extracts from D. morbifera [13]. In addition, rutin,
a bioflavonoid isolated from D. morbifera, significantly
decreases rotenone-induced generation of reactive oxy-
gen species in SH-SY5Y cells and mitochondrial mem-
brane potential depletion [14]. However, there are no
reports on the effects of DMS on oxidative stress and
antioxidant enzyme activity after Cd exposure. There-
fore, in this study, we investigated the effects of DMS
treatment on Cd excretion from the kidney and hippo-
campus, and on antioxidant enzyme activity and lipid
peroxidation in the hippocampus of Cd-exposed rats.
Methods
Experimental animals
Male Sprague-Dawley rats were purchased from Orient
Bio Inc. (Seongnam, South Korea). Rats were housed in
a conventional animal facility at 23°C with 60% humid-
ity, a 12 h/12 h light/dark cycle, and free access to food
and tap water. The handling and care of the animals
conformed to the guidelines established in order to com-
ply with current international laws and policies (NIH
Guide for the Care and Use of Laboratory Animals, NIH
Publication No. 85-23, 1985, revised 1996), and were
approved by the Institutional Animal Care and Use
Committee (IACUC) of Seoul National University (SNU-
130522-1). All of the experiments were conducted with an
effort to minimize the number of animals used and the suf-
fering caused by the procedures used in the study.
Preparation of DMS
Fresh Dendropanax morbifera Léveille was purchased
from a local market on Jeju Island in Korea. The plant
was authenticated by two practitioners of traditional
Asian medicine, and a voucher specimen was deposited
with Egreen Co. Ltd. (deposition number: 2013-001).
Stems from the plant samples (100 g) were chopped,blended, soaked in 2 L of 80% ethanol, and refluxed
three times at 20°C for 2 h. The insoluble materials were
removed by centrifugation at 10,000 × g for 30 min, and
the resulting supernatant was concentrated and freeze-
dried to yield a powder (yield: 4.7%). Before each experi-
ment, the dried extract was dissolved in distilled and
deionized water.
Administration of Cd and DMS
Cadmium chloride was obtained from Sigma-Aldrich
(St. Louis, MO, USA). Animals were divided into 4 treat-
ment groups (n = 29 in each group): a control group, a
group treated with 100 mg/kg DMS, a group treated with
2 mg/kg Cd, and a group treated with Cd and DMS. Cd
and/or DMS were administered orally to 7-week-old rats
once a day for 4 weeks.
Cd level in the blood, brain, and kidney
To measure Cd concentration in the blood and brain
and kidney tissues, control, DMS-, Cd-, and Cd-DMS-
treated rats (n = 7 in each group) were anesthetized with
100 mg/kg of Zoletil 50® (Virbac, Carros, France) and the
blood, hippocampi, and kidneys were extracted. Blood
samples were allowed to clot, after which they were cen-
trifuged for 30 min at 1,000 g to separate the serum.
Hippocampi and kidneys were weighed in glass vessels,
and tissues were digested by adding 3-8 mL of HNO3 at
130°C for 3 h, after which 2 mL of H2O2 was added and
the samples were heated for 1 h. Serum and digested
samples were transferred to polypropylene flasks for Cd
determination. Cd determination was performed by using
inductively coupled plasma mass spectrometry (ICP-MS;
PerkinElmer Sciex, Thornhill, Canada).
Measurement of reactive oxygen species (ROS)
production in the hippocampus
The effects of Cd and/or DMS on ROS production in
the hippocampus of control, DMS-, Cd-, and Cd-DMS-
treated rats (n = 5 in each group) were assessed using
the fluorescent probe 2′,7′-dichlorofluorescin diacetate
(DCFH-DA) [15]. Intracellular ROS oxidize DCFH-DA
to dichlorofluorescein (DCF), an intense fluorescent
chemical. Four weeks after Cd treatment, rats in each
group were deeply anesthetized and euthanized by de-
capitation. Brain mitochondria were obtained as described
previously [16]. Mitochondrial protein quantification was
determined by the Bradford method [17] using bovine
serum albumin (BSA) as the standard. Mitochondria iso-
lated from different groups (0.5 mg/mL) were incubated
with 10 μMDCFH-DA at 37°C for 60 min, and the fluores-
cence intensity of DCF was measured at an excitation
wavelength of 488 nm and emission wavelength of 527 nm
in a microplate reader (SpectraMax M5, Molecular Devices
LLC, Sunnyvale, CA, USA).
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homogenates
The effects of Cd and/or DMS on lipid peroxidation
levels in control, DMS-, Cd-, and Cd-DMS-treated rats
(n = 5 in each group) were assessed by measuring malon-
dialdehyde (MDA) formation using the Bioxytech MDA-
586 kit (Oxis Research, Portland, OR, USA). Briefly,
bilateral hippocampi were collected using a surgical blade
and the left part was homogenized in 20 mM PBS
(pH 7.4) containing 5 mM butylated hydroxytoluene. After
centrifugation of the homogenates at 3000 × g for 10 min
at 4°C, the supernatants were collected. For each reaction,
10 μL of probucol and 640 μL of diluted R1 reagent
(1:3 of methanol:N-methyl-2-phenylindole) were added
and mixed with 150 μL of 12 N HCl. Each reaction was in-
cubated at 45°C for 60 min and centrifuged at 10,000 × g
for 10 min. The supernatant was collected and MDA for-
mation was determined by measuring the absorbance at
586 nm. MDA data were normalized to the protein con-
centration of each sample.
Protein carbonyl levels
To elucidate the effects of Cd and/or DMS on protein
modification, carbonylation of proteins as a result of oxi-
dative stress was determined in control, DMS-, Cd-, and
Cd-DMS-treated rats (n = 5 in each group) by the Levine
method [18]. The color intensity of the supernatant was
measured at 370 nm using a spectrophotometer against
2 M HCl. Carbonyl content was calculated using the molar
extinction coefficient (21 × 103 L/mol cm), and results were
expressed as nmol/mg of protein.
Measurement of antioxidant activity in hippocampal
homogenates
To elucidate the effects of Cd and/or DMS on Cu, Zn-
superoxide dismutase 1 (SOD1), catalase (CAT), and
glutathione peroxidase (GPx), the activity of these en-
zymes was measured in control, DMS-, Cd-, and Cd-
DMS-treated rats (n = 7 in each group). Briefly, the right
part of the hippocampus (matching the right part used
for measurement of lipid peroxidation) was homoge-
nized in 10 mM Tris buffer containing 1 mM EDTA and
1 mM PMSF. The homogenates were centrifuged at
600 × g for 10 min, and then centrifuged at 13,000 × g
for 20 min at 4°C.
SOD1 activity was measured by monitoring its cap-
acity to inhibit the reduction of ferricytochrome c by
xanthine/xanthine oxidase as described by McCord and
Fridovich [19]. SOD1 activity staining was performed by
electrophoresis in 10% native polyacrylamide gels and vi-
sualized as described by Beauchamp and Fridovich [20].
Briefly, the gel was soaked in 2.45 mM nitroblue tetrazo-
lium solution for 15 min, followed by 30 min in 28 mM
N, N, N′′, N′′-tetramethylethylene diamine and 28 μMriboflavin in 0.36 mM potassium phosphate buffer
(pH 7.8). The gel was exposed to a fluorescent light source
until the bands showed maximum resolution.
CAT activity was assayed at 25°C by determining the
rate of H2O2 degradation in 10 mM of potassium phos-
phate buffer (pH 7.0) according to Aebi’s method [21].
An extinction coefficient of 43.6 mM/cm was used for
the calculations. One unit is defined as 1 pmol of H2O2
consumed per min and the specific activity is reported
as units per mg of protein.
GPx activity was assayed by measuring nicotina-
mide adenine dinucleotide phosphate (NADPH) oxidation
with t-butyl-hydroperoxide as a substrate according to the
method of Maral et al. [22]. Briefly, the reaction was
carried out at 25°C in 600 μL of a solution containing
100 mM potassium phosphate buffer (pH 7.7), 1 mM
EDTA, 0.4 mM sodium azide, 2 mM glutathione, 0.1 mM
NADPH, 0.62 U of glutathione reductase, and 50 μL of
homogenate.
Measurement of glutathione-related enzymes in
hippocampal homogenates
The effects of Cd and/or DMS on glutathione-related
enzymes in the hippocampus of control, DMS-, Cd-, and
Cd-DMS-treated rats (n = 5 in each group) were investi-
gated using the tissue samples obtained for the measure-
ment of protein carbonyl levels. Glutathione-S-transferase
(GST) activity was determined spectrophotometrically
using 1-chloro-2,4-dinitrobenzene as a substrate [23].
Glutathione reductase (GR), which has been shown
to utilize NADPH to convert oxidized glutathione (GSSG)
to the reduced form (GSH), was assayed by the method of
Horn and Burns [24].
Statistical analysis
All data are expressed as mean ± standard error of the
mean (SEM). To determine the effects of Cd and DMS,
differences between the means were statistically analyzed
using two-way analysis of variance (ANOVA) with re-
peated measures and Bonferroni’s post hoc test.
Results
Quantification of Cd content in kidney and brain tissues
The ICP-MS method was used to determine Cd concen-
trations in serum, kidney, and hippocampal tissues. Cd
concentrations in serum, kidney, and hippocampal
tissues were similar in the control and DMS-treated
groups. In the Cd-treated group, Cd concentrations in
the serum and kidney were significantly higher than
those in the control group. In contrast, there was no sig-
nificant difference in the Cd concentration in the hippo-
campus between the control and DMS-treated groups,
although the level was increased 1.57-fold in the control
group. In the Cd-DMS-treated group, Cd concentrations
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those in the Cd-treated group (Table 1).
Effects of Cd and/or DMS on ROS formation in
hippocampal homogenates
DCF fluorescence levels were similar in the control and
DMS-treated groups. DCF fluorescence was significantly
increased (1.71-fold) in the Cd-treated group in com-
parison with that of the control group. However, the
MDA level of the Cd-DMS-treated group was signifi-
cantly decreased to 74.4% of that of the Cd-treated
group (Figure 1A).
Effects of Cd and/or DMS on protein carbonyl levels in
hippocampal homogenates
Protein carbonyl levels were similar in the control and
DMS-treated groups. However, the protein carbonyl
level of the Cd-treated group was significantly increased
(2.4-fold) in comparison with that of the control group.
The protein carbonyl level of the Cd-DMS-treated group
was significantly decreased to 57.4% of that of the Cd-
treated group (Figure 1B).
Effects of Cd and/or DMS on lipid peroxidation in
hippocampal homogenates
MDA levels in hippocampal homogenates were 25.8 and
25.4 nmol/mg protein in the control and DMS-treated
groups, respectively. The MDA level of the Cd-treated
group was 2.2-fold higher than that of the control group.
However, the MDA level of the Cd-DMS-treated group
was significantly lower (39.1 nmol/mg protein) than that
of the Cd-treated group (Figure 1C).
Effects of Cd and/or DMS on SOD1, CAT, and GPx
activities in hippocampal homogenates
SOD1, CAT, and GPx activities in the control group
were 15.61, 1.739, and 198.1 U/mg protein, respectively.
In the DMS-treated group, SOD1 and GPx activities
were slightly higher than those in the control group.
However, CAT activity was lower than that of the con-
trol group. In the Cd-treated group, SOD1, CAT, and
GPx activities were significantly lower than those in the
control group. The effect of Cd exposure on SOD1 ac-
tivity was its most pronounced effect. SOD1, CAT, andTable 1 Effects of cadmium (Cd) and/or Dendropanax morbife
blood and hippocampal and kidney tissues of rats
Tissue Control DMS
Blood 4.12 ± 1.12 3.48 ± 0.84
Hippocampus 0.014 ± 0.0009 0.012 ± 0.0
Kidney 0.015 ± 0.0028 0.014 ± 0.0
* Indicates a significant difference between the control and Cd groups (P <0.05); # I
n = 7 per group). The data represent the mean ± standard error of the mean (SEM).GPx activities in the Cd-DMS-treated group were sig-
nificantly higher than those in the Cd-treated group, and
the greatest increase was in GPx activity (Figure 2).
Effects of Cd and/or DMS on glutathione-related enzymes
in hippocampal homogenates
In the control and DMS-treated groups, GSH level, TSH
(total sulfhydryl groups) level, and the activities of GR
and GST were similar in the hippocampal homogenates.
In the Cd-treated group, TSH level and GR activity were
significantly decreased to 53.5% and 37.8% of those of
the control group, respectively. In contrast, GST activity
in the Cd-treated group was significantly increased to
147.7% of that of the control group. In the Cd-DMS-
treated group, TSH level and GR activity were signifi-
cantly increased to 172.9% and 174.7% of those of the
control group, respectively. GST activity in the Cd-
DMS-treated group was significantly decreased to 58.5%
of that of the Cd-treated group (Figure 3).
Discussion
Cd causes toxicity by disturbing the cellular homeostasis
of essential metal ions such as copper and zinc. In
addition, Cd affects antioxidant enzymes, which use cop-
per and zinc, through oxidation or peroxidation in the
brain [25]. In contrast, DMS has high ferric-reducing
ability and contains high levels of phenolic compounds
[13]. Therefore, we investigated the effects of DMS on
Cd-induced oxidative stress in the hippocampus. Chronic
administration of Cd significantly increased Cd levels in
kidney and hippocampal tissues. Supplementation with
DMS markedly decreased the Cd concentration in the kid-
neys, but Cd levels were only slightly decreased in hippo-
campal tissue.
Cd can affect the integrity and permeability of the vas-
cular endothelium, penetrate the blood-brain barrier,
and accumulate in the brain [26-28]. In this study, we
measured mitochondrial ROS formation after Cd expos-
ure based on the conversion of DCFH-DA to DCF. Ex-
posure to Cd significantly increased ROS formation. In
addition, we observed decreased TSH content and in-
creased protein carbonylation because the oxidative effect
of Cd is associated mainly with the depletion of sulfhydryl
group-containing compounds [29]. Cd administrationra stem extract (DMS) on Cd concentration (μg/g) in the
Cd Cd/DMS
39.7 ± 4.12* 26.9 ± 5.36*,#
012 0.022 ± 0.0012 0.019 ± 0.0011
041 4.365 ± 1.4105* 3.523 ± 1.1254*,#
ndicates a significant difference between the Cd and Cd/DMS groups (P <0.05;
Figure 1 Levels of intracellular reactive oxygen species
production as determined by 2′,7′-dichlorofluorescein (DCF)
levels (A), protein carbonyl levels (B), and malondialdehyde
(MDA) levels (C) in the hippocampi of control, DMS-, Cd-,
and Cd-DMS-treated rats. * Indicates a significant difference
between the control and Cd groups (P <0.05); # indicates a
significant difference between the Cd and Cd/DMS groups (P <0.05;
n = 5-7 per group). DCF, protein carbonyl, and MDA levels are
significantly higher in the Cd group and the administration of
DMS to Cd-exposed rats leads to a decrease in DCF, protein carbonyl,
and MDA levels. The data represent means ± standard error of the
mean (SEM).
Figure 2 Cu, Zn-Superoxide dismutase 1 (SOD1), catalase (CAT),
and glutathione peroxidase (GPx) activity in the hippocampi of
control, DMS-, Cd-, Cd-DMS-treated rats. * Indicates a significant
difference between the control and Cd groups (P <0.05); # indicates
a significant difference between the Cd and Cd/DMS groups (P <0.05;
n = 7 per group). Antioxidant enzyme activities are significantly lower in
the Cd group and the administration of DMS to Cd-exposed rats
ameliorates the reduction of enzyme activities. The effect on GPx
activity is greater than that on SOD1 or CAT activities. The data
represent means ± standard error of the mean (SEM).
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tein carbonylation in the hippocampus. This result con-
firmed those of previous studies, which showed that Cd
Figure 3 Total sulfhydryl groups (TSH), reduced glutathione (GSH), glutathione reductase (GR), and glutathione-S-transferase (GST) in
the hippocampi of control, DMS-, Cd-, Cd/DMS-treated rats. * Indicates a significant difference between the control and Cd groups (P <0.05);
# indicates a significant difference between the Cd and Cd/DMS groups (P <0.05; n = 5 per group). GR activity, TSH levels, and GSH levels are
significantly increased after exposure to Cd, while GST activity is significantly increased. The administration of DMS to Cd-exposed rats ameliorates
or reverses the changes of enzyme activities or levels. The data represent means ± standard error of the mean (SEM).
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actions in the brain, including the hippocampus [30], and
kidney [31]. We also estimated lipid peroxidation by
measuring MDA level, which is a major oxidation prod-
uct of peroxidized polyunsaturated fatty acids [32]. Re-
peated administration of Cd significantly increased MDA
levels in the hippocampus. This result is consistent with
previous studies showing that exposure to Cd for 30 days
significantly increases MDA levels in hippocampal tissue
[33,34]. However, supplementation with DMS signifi-
cantly reduced MDA levels in the hippocampus. This
suggests that DMS potently inhibits Cd-induced lipid
peroxidation in the hippocampus. This result is in ac-
cordance with a recent study showing that rutin isolated
from Dendropanax morbifera Léveille significantly de-
creases rotenone-induced generation of reactive oxygen
species in SH-SY5Y cells [14].
In this study, we also determined the effects of DMS
and/or Cd on the activity of SOD1, CAT, and GPx in the
hippocampus because Cd has been shown to inhibit
antioxidant enzymes [33-38]. We found that Cd expos-
ure for 4 weeks significantly reduced the activities of
SOD1, CAT, and GPx in the hippocampus. These data
are in agreement with those of previous studies showing
that GPx, SOD1, Mn-SOD, and CAT activities in thehippocampus are significantly decreased after Cd expos-
ure for 30 days [33,34]. Cd attacks intracellular sulfhy-
dryl groups and disrupts organelles [39], because most
antioxidant enzymes become inactive when Cd binds to
their active sites [40]. Supplementation with DMS pre-
vented the Cd-induced inhibition of SOD1, CAT, and
GPx activities in the hippocampus, suggesting that the
antioxidant effects of DMS may attenuate Cd-induced
neurotoxicity in the hippocampus.
We focused on glutathione-related enzymes because
the increase in activity after DMS treatment in Cd-
exposed rats was most prominent for GPx, among the
antioxidative enzymes. Exposure to Cd significantly de-
creased GR activity, TSH level, and GSH level, while
GST activity was significantly increased. The decrease of
GR activity, TSH level, and GSH level after Cd exposure
could be responsible for increased ROS levels and subse-
quent lipid peroxidation and protein carbonylation in
the brain, because GSH can directly scavenge ROS or
act as a substrate for GPx and GST in the detoxification
of hydrogen peroxide [41]. DMS administration signifi-
cantly ameliorated changes in glutathione-related en-
zymes in the hippocampus caused by Cd exposure, and
this effect may be associated with direct reductions in
ROS levels.
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The administration of DMS promotes the excretion of
Cd from the kidney and ameliorates Cd-induced in-
creases in ROS, lipid peroxidation, and protein carbonyl
levels, which are modified by oxidative stress. In addition,
DMS efficiently attenuates Cd-induced deficits in SOD1,
CAT, GPx, and glutathione-related enzyme activities in the
hippocampus.
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